Préparer l’avenir de la génomique microbienne

PromethION 24 | One device, multiple experiments

PromethION 24 | On-demand, flexible sequencing

PromethION 24 | Sequence at scale

WYMM Tour 2025 | Register for an event near you | What you're missing matters

ナノポアダイレクトRNAシークエンスであなたの研究を加速

データ解析入門

Discovery of deeply intronic damaging mutations with nanopore sequencing

Resolving complex genomic structures and regulation patterns in cervical cancer

Improved detection and clinical interpretation of rare disease variants

Exploring how alternative splicing and gene isoforms influence disease

How to get started with nanopore sequencing and plan your experiment

Enhancing cell and gene therapy success with multi-omic sequencing

Advances in genomic profiling of respiratory viral pathogens

Oxford Nanopore announce new Chief Scientific Officer and Chief Product and Marketing Officer

Building a rapid, targeted and responsive infectious disease system

Unlocking genomic insights: real-time sequencing with a palm-sized device

Redefining cancer characterisation and predisposition insight with nanopore sequencing

Driving better outcomes for patients health systems, and populations

Genomics in early detection and precision therapies

ORG.one — enabling endangered species to bounce back

Precision genomics: the future of food safety

Introducing ElysION: Oxford Nanopore's sample-to-answer sequencing solution

Comprehensive characterisation of the mouse retina transcriptome using long-read RNA sequencing

ElysION: step-by-step demo

A survey of RNA modifications across the human transcriptome by direct RNA nanopore sequencing

Consolidation of a long-read sequencing platform in southern South America

Unlocking comprehensive genome for large-scale projects

Showcase Biosurveillance

PRECISE: Revealing new insights into population scale genomics in Singapore

Nanopore sequencing at the intersection between the clinic and biotech

Microbial identification in biopharma

Antibody discovery through single-cell transcriptomics and haplotype-resolved germline sequencing

Using nanopore sequencing for mRNA vaccine quality control a journey from R&D to GMP

Adventitious agent screening by long-read NGS

The art of GMP in the world of NGS: trials, tribulations & a whole lot of acronyms — a success story

The potential of therapeutic mRNA — and how to measure it

QC made easy, a practical overview of nanopore QC tests for biomanufacturing

Nanopore sequencing and functional screening of AAV genomes for optimal production and function

NESSI-Seq novel cfDNA methylation assays for biomarker discovery and precision medicine

Application of nanopore long-read sequencing to sterility testing for cell therapy products

A sensitive sample preparation pipeline for adventitious virus detection using nanopore sequencing

Precision cell engineering enabled through nanopore sequencing

Implementation of sequencing in a regulated environment

Secondary analysis update

Bacterial isolate and plasmid sequencing

Direct RNA basecaller update

Dorado latest developments and future directions

How good is good enough

Diverse structural variants cluster near breakage-fusion-bridge site in cancer genomes

Detection of hidden antibiotic resistance through real-time genomics

Nanopore-based random genomic sampling for intraoperative diagnosis of brain tumors and beyond

Unraveling gene expression patterns in pediatric germ cell tumors a nanopore sequencing approach

Decoding the spliced HIV-1 transcriptome with accurate long-read RNA sequencing

Is the water safe to drink? The rapid test is the missing link

Studying disease-causing polymorphic transposable element insertions using nanopore sequencing

Maximizing the power of genomic sequencing in pediatric rare disease

Detection of mosaic and somatic structural variants with Sniffles2

Evaluating the quality of long-read phasing methods in clinically relevant genes

needLR a structural variant filtering and prioritization tool for long-read sequencing data